Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the effective delivery of combination drugs.
“The BerryHaler demonstrates our commitment to delivering patient-centred products for our pharmaceutical customers with customisable, off-the-shelf solutions that help bring new treatments to market quickly,” said Marco Franza, Sales and Business Development Director for Berry Global Healthcare. “By partnering with our experts, customers can reduce investment costs and development time, relying on Berry for the device and focusing their resources on formulation development.”
The BerryHaler offers pharmaceutical companies a ready-to-use and customisable solution for the fast-to-market introduction of inhalation treatments that relieve the symptoms of Chronic Obstructive Pulmonary Disease (COPD), asthma, and other lung disorders. The patented design incorporates dual chamber Puck properties that enable the delivery of 30 doses of double and triple formulations simultaneously to the patient.
The all-plastic inhaler with no metal parts is ideal for more complex inhalation treatments, including those that would otherwise require several different inhalers to achieve the correct dosage and combination drug treatments that cannot be combined in a single blend. Additionally, the BerryHaler provides easy and intuitive operation for various patient profiles, including seniors and children.
Special features include a bi-directional non-detachable mouthpiece cover that enhances ease of use and helps prevent cover loss, protecting the formulation and providing a more hygienic application for patients. The device also emits an audible signal when opening and closing the mouthpiece so that users know it has been fully opened for inhalation and then safely closed. The integrated dose counter helps patients to accurately monitor medication usage and remaining doses and avoid accidental over-or underdosage.
The BerryHaler has been developed as part of Berry’s ‘Dose Better’ initiative, which is focused on the introduction of patient-centred packaging and drug delivery devices that deliver accurate and user-friendly dosing administration and support improved medicine adherence.
The BerryHaler was launched at Pharmapack 2024. For more information, visit or email healthcare@berryglobal.com.
Ends
About Berry
At Berry Global Group, Inc. (NYSE: BERY), we create innovative packaging solutions that we believe make life better for people and the planet. We do this every day by leveraging our unmatched global capabilities, sustainability leadership, and deep innovation expertise to serve customers of all sizes around the world. Harnessing the strength in our diversity and industry-leading talent of over 40,000 global employees across more than 250 locations, we partner with customers to develop, design, and manufacture innovative products with an eye toward the circular economy. The challenges we solve and the innovations we pioneer benefit our customers at every stage of their journey. For more information, visit our website, or connect with us on LinkedIn or X.
